myriameat achieves successful differentiation of roe deer iPSCs.

Goettingen/Munich, May 26, 2026 - myriameat, a pioneer in cultured meat derived from pluripotent stem cells, today announced a significant scientific breakthrough: For the first time, the team has succeeded in generating a pluripotent stem cell line from roe deer and successfully converting it into real roe deer muscle cells using its patented differentiation protocol.

With this step, myriameat lays the technological foundation for the development of cultured roe deer fillet. The roe deer muscle cells obtained are a key building block for producing real roe deer meat in the future, independent of slaughter, game harvesting, or conventional animal husbandry.

The new roe deer iPSC line expands myriameat's platform technology to another animal species and demonstrates that the company's approach is not limited to pork. Following previous successes with cultured pork, the successful differentiation of roe deer iPSCs opens new perspectives for high-quality cuts of meat derived from cell culture.

The focus of the work is on the production of real muscle cells. myriameat is thus not pursuing the goal of a substitute product, but rather the development of real cell-based meat. The approach combines modern stem cell biology with the vision of a more sustainable, ethically responsible, and future-proof meat production.

Roe deer meat is considered a high-quality, distinctive meat with a special culinary tradition. At the same time, its availability is naturally limited. Cultured roe deer meat could, in the long term, open up a new option for making special meat qualities accessible without having to slaughter animals and without placing additional pressure on wildlife populations.

The successful differentiation marks an early but crucial step in development. Building on this, myriameat aims to further characterize the cell line, optimize process steps, and advance the application of the technology toward structured muscle tissue and, ultimately, cultured venison fillet products.

_"This milestone shows that our platform technology is not limited to individual animal species but can be transferred to other species. Roe deer meat from cell culture is no longer a vision for us--it is a concrete next step in development."_

- Florian Huettner, CEO of myriameat

myriameat GmbH
Nussbaumstrasse 10
80336 Muenchen
Germany

https://www.myriameat.com

Herr Dr.Timm Eifler

marketing@myriameat.com

Founded in Munich and Goettingen in 2022, the biotech startup MyriaMeat is a pioneer in the production of 100% real cultivated meat based on pluripotent stem cells.

Building on decades of medical research at the University of Goettingen, MyriaMeat offers sustainable and ethically responsible alternatives to conventional meat. The goal is to establish a platform that enables the production of high-quality, pure meat as well as a variety of other meat-based products, positioning the company as a key partner for the development of innovative foods using alternative proteins.

The cultivated meat developed by MyriaMeat not only offers ecological advantages but also enables a significant improvement in animal welfare, as animals no longer need to be slaughtered for meat production. With its groundbreaking research, MyriaMeat is setting new standards for the future of nutrition. MyriaMeat develops real meat from pluripotent stem cells for sustainable and ethical nutrition.

The company uses patented technology to produce meat from animal cells and is driving the development of cultivated meat products without plant-based substitutes. Following successes with pork, myriameat is now expanding its platform to include cell-cultured venison.

This release was published on openPR.